tirzepatide or semaglutide better for weight loss I compare two medications with my patients every single week. Here's what the data actually shows. (Ozempic/Wegovy) delivered a 13.7% average weight loss in clinical trials. That's significant. But Zepbound vs Wegovy: Tirzepatide vs

The program is built for repeatability and documentation discipline, with stable catalog references, batch traceability, and specification forward listings intended to support multi run research plans

For show notes and additional resources, please visit hubermanlab.com

When used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, which may require dose adjustments of these medications

DOX increased nitrotyrosine abundance by 68% compared to controls, reflecting heightened oxidative stress

Preclinical data suggests GLP-1 receptor activation may protect intestinal mucosal integrity and reduce intestinal inflammation

Semaglutidea GLP-1 receptor agonist originally developed for type 2 diabeteshas emerged as a leading treatment for weight loss, with clinical trials showing an average 15% body weight reduction over 68 weeks